{"id":"NCT04711837","sponsor":"Haisco-USA Pharmaceuticals, Inc.","briefTitle":"Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery","officialTitle":"A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-02-11","primaryCompletion":"2022-04-13","completion":"2022-04-20","firstPosted":"2021-01-15","resultsPosted":"2023-05-26","lastUpdate":"2025-09-04"},"enrollment":255,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Anesthesia"],"interventions":[{"type":"DRUG","name":"HSK3486","otherNames":[]},{"type":"DRUG","name":"Propofol","otherNames":["Diprivan"]}],"arms":[{"label":"HSK3486","type":"EXPERIMENTAL"},{"label":"Propofol","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multicenter, randomized, double-blinded, propofol-controlled, Phase 3 clinical study to evaluate the efficacy and safety of HSK3486 for induction of general anesthesia in adults undergoing elective surgery.","primaryOutcome":{"measure":"Number of Participants With Successful Anesthesia Induction","timeFrame":"From start of drug administration to MOAA/S â‰¤1 (up to 5 minutes)","effectByArm":[{"arm":"HSK3486","deltaMin":163,"sd":null},{"arm":"Propofol","deltaMin":81,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":13,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":168},"commonTop":["Hypotension","Nausea","Procedural Pain"]}}